Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 364

1.

Prognosis of amyotrophic lateral sclerosis patients undergoing tracheostomy invasive ventilation therapy in Japan.

Hayashi N, Atsuta N, Yokoi D, Nakamura R, Nakatochi M, Katsuno M, Izumi Y, Kanai K, Hattori N, Taniguchi A, Morita M, Kano O, Shibuya K, Kuwabara S, Suzuki N, Aoki M, Aiba I, Mizoguchi K, Oda M, Kaji R, Sobue G.

J Neurol Neurosurg Psychiatry. 2020 Jan 14. pii: jnnp-2019-322213. doi: 10.1136/jnnp-2019-322213. [Epub ahead of print]

PMID:
31937581
2.

Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective Study.

Tanaka Y, Tsuboi T, Watanabe H, Nakatsubo D, Maesawa S, Kato S, Kajita Y, Sato M, Oodake R, Hattori M, Yamamoto M, Wakabayashi T, Katsuno M, Sobue G.

J Parkinsons Dis. 2020;10(1):131-140. doi: 10.3233/JPD-191798.

PMID:
31884493
3.

Impact of orthostatic hypotension on wheelchair use in patients with Parkinson's disease.

Nakamura T, Suzuki M, Ueda M, Harada Y, Hirayama M, Katsuno M.

J Neural Transm (Vienna). 2019 Dec 23. doi: 10.1007/s00702-019-02127-4. [Epub ahead of print]

PMID:
31873768
4.

[Late phase II/III study of BYM338 in patients with sporadic inclusion body myositis (RESILIENT): Japanese cohort data].

Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Teshima R, Inamura T, Nishino I, Aoki M.

Rinsho Shinkeigaku. 2019 Dec 25;59(12):806-813. doi: 10.5692/clinicalneurol.cn-001325. Epub 2019 Nov 23. Japanese.

PMID:
31761834
5.

[The Role of Patient Registry in the Care and Therapeutic Development for Patients with Amyotrophic Lateral Sclerosis: JaCALS].

Atsuta N, Nakamura R, Hayashi N, Tohnai G, Katsuno M, Sobue G.

Brain Nerve. 2019 Nov;71(11):1215-1225. doi: 10.11477/mf.1416201431. Japanese.

PMID:
31722307
6.

Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.

Sakakibara S, Hashimoto R, Katayama T, Kenjyo M, Yokokawa Y, Saito Y, Hirakawa A, Ito M, Nakamura T, Hara K, Hashizume A, Aiba I, Inukai A, Katsuno M.

J Parkinsons Dis. 2020;10(1):123-130. doi: 10.3233/JPD-191710.

PMID:
31707374
7.

Complement deposition and macrophage-induced demyelination in CIDP with anti-LM1 antibodies.

Koike H, Ikeda S, Fukami Y, Nishi R, Kawagashira Y, Iijima M, Nakamura T, Kuwahara M, Kusunoki S, Katsuno M, Sobue G.

J Neurol Sci. 2020 Jan 15;408:116509. doi: 10.1016/j.jns.2019.116509. Epub 2019 Oct 17. No abstract available.

PMID:
31698166
8.

Nasometric Scores in spinal and bulbar muscular atrophy - Effects of palatal lift prosthesis on dysarthria and dysphagia.

Tanaka S, Hashizume A, Hijikata Y, Yamada S, Ito D, Nakayama A, Kurita K, Yogo H, Banno H, Suzuki K, Yamamoto M, Sobue G, Katsuno M.

J Neurol Sci. 2019 Dec 15;407:116503. doi: 10.1016/j.jns.2019.116503. Epub 2019 Oct 15.

PMID:
31669728
9.

Expanding the spectrum of transthyretin amyloidosis.

Koike H, Katsuno M.

Muscle Nerve. 2020 Jan;61(1):3-4. doi: 10.1002/mus.26741. Epub 2019 Nov 6. No abstract available.

PMID:
31639223
10.

Demyelinating Neuropathy Due to Intravascular Large B-cell Lymphoma: A Case Report.

Fukami Y, Koike H, Iijima M, Hagita J, Niwa H, Nishi R, Kawagashira Y, Katsuno M.

Intern Med. 2019 Oct 7. doi: 10.2169/internalmedicine.3228-19. [Epub ahead of print]

11.

Cilostazol use is associated with FIM cognitive improvement during convalescent rehabilitation in patients with ischemic stroke: a retrospective study.

Senda J, Ito K, Kotake T, Kanamori M, Kishimoto H, Kadono I, Nakagawa-Senda H, Wakai K, Katsuno M, Nishida Y, Ishiguro N, Sobue G.

Nagoya J Med Sci. 2019 Aug;81(3):359-373. doi: 10.18999/nagjms.81.3.359.

12.

Zygomatic Anterior Temporal Approach for High-position Upper Basilar Aneurysm.

Katsuno M, Tanikawa R.

Neurol Med Chir (Tokyo). 2019 Nov 15;59(11):430-435. doi: 10.2176/nmc.oa.2019-0090. Epub 2019 Sep 22.

13.

Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy.

Iida M, Sahashi K, Kondo N, Nakatsuji H, Tohnai G, Tsutsumi Y, Noda S, Murakami A, Onodera K, Okada Y, Nakatochi M, Tsukagoshi Okabe Y, Shimizu S, Mizuno M, Adachi H, Okano H, Sobue G, Katsuno M.

Nat Commun. 2019 Sep 19;10(1):4262. doi: 10.1038/s41467-019-12282-7.

14.

Semantic deficits in ALS related to right lingual/fusiform gyrus network involvement.

Ogura A, Watanabe H, Kawabata K, Ohdake R, Tanaka Y, Masuda M, Kato T, Imai K, Yokoi T, Hara K, Bagarinao E, Riku Y, Nakamura R, Kawai Y, Nakatochi M, Atsuta N, Katsuno M, Sobue G.

EBioMedicine. 2019 Sep;47:506-517. doi: 10.1016/j.ebiom.2019.08.022. Epub 2019 Sep 3.

15.

[Multiple mononeuropathy associated with systemic sclerosis with vasculitis confirmed by nerve biopsy: a case report].

Kano Y, Kato H, Koike H, Katsuno M, Oguri T, Yuasa H.

Rinsho Shinkeigaku. 2019 Sep 25;59(9):604-606. doi: 10.5692/clinicalneurol.cn-001320. Epub 2019 Aug 30. Japanese.

PMID:
31474645
16.

Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis.

Ito D, Hashizume A, Hijikata Y, Yamada S, Iguchi Y, Iida M, Kishimoto Y, Moriyoshi H, Hirakawa A, Katsuno M.

J Neurol. 2019 Dec;266(12):2952-2961. doi: 10.1007/s00415-019-09507-6. Epub 2019 Aug 27.

PMID:
31456060
17.

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.

Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Auberson LZ, Wu M, de Vera A, Papanicolaou DA, Amato AA; RESILIENT Study Group.

Lancet Neurol. 2019 Sep;18(9):834-844. doi: 10.1016/S1474-4422(19)30200-5.

PMID:
31397289
18.

Reorganization of brain networks and its association with general cognitive performance over the adult lifespan.

Bagarinao E, Watanabe H, Maesawa S, Mori D, Hara K, Kawabata K, Yoneyama N, Ohdake R, Imai K, Masuda M, Yokoi T, Ogura A, Taoka T, Koyama S, Tanabe HC, Katsuno M, Wakabayashi T, Kuzuya M, Ozaki N, Hoshiyama M, Isoda H, Naganawa S, Sobue G.

Sci Rep. 2019 Aug 6;9(1):11352. doi: 10.1038/s41598-019-47922-x.

19.

TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets.

Araki K, Araki A, Honda D, Izumoto T, Hashizume A, Hijikata Y, Yamada S, Iguchi Y, Hara A, Ikumi K, Kawai K, Ishigaki S, Nakamichi Y, Tsunekawa S, Seino Y, Yamamoto A, Takayama Y, Hidaka S, Tominaga M, Ohara-Imaizumi M, Suzuki A, Ishiguro H, Enomoto A, Yoshida M, Arima H, Muramatsu SI, Sobue G, Katsuno M.

J Clin Invest. 2019 Jul 29;130:3578-3593. doi: 10.1172/JCI124481. eCollection 2019 Jul 29.

20.

Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met).

Koike H, Nakamura T, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Yasuda T, Mukai E, Date Y, Shiomi K, Nakazato M, Katsuno M, Sobue G.

Amyloid. 2019;26(sup1):24-25. doi: 10.1080/13506129.2019.1582495. No abstract available.

PMID:
31343348
21.

Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study.

Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G.

Amyloid. 2019;26(sup1):26. doi: 10.1080/13506129.2019.1582496. No abstract available.

PMID:
31343346
22.

Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation.

Nakamura T, Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G.

Amyloid. 2019;26(sup1):6. doi: 10.1080/13506129.2019.1582018. No abstract available.

PMID:
31343341
23.

Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation.

Koike H, Nakamura T, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G.

Amyloid. 2019;26(sup1):13-14. doi: 10.1080/13506129.2019.1582023. No abstract available.

PMID:
31343285
24.

Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease.

Sone J, Mitsuhashi S, Fujita A, Mizuguchi T, Hamanaka K, Mori K, Koike H, Hashiguchi A, Takashima H, Sugiyama H, Kohno Y, Takiyama Y, Maeda K, Doi H, Koyano S, Takeuchi H, Kawamoto M, Kohara N, Ando T, Ieda T, Kita Y, Kokubun N, Tsuboi Y, Katoh K, Kino Y, Katsuno M, Iwasaki Y, Yoshida M, Tanaka F, Suzuki IK, Frith MC, Matsumoto N, Sobue G.

Nat Genet. 2019 Aug;51(8):1215-1221. doi: 10.1038/s41588-019-0459-y. Epub 2019 Jul 22.

PMID:
31332381
25.

A behavior-based drug screening system using a Caenorhabditis elegans model of motor neuron disease.

Ikenaka K, Tsukada Y, Giles AC, Arai T, Nakadera Y, Nakano S, Kawai K, Mochizuki H, Katsuno M, Sobue G, Mori I.

Sci Rep. 2019 Jul 12;9(1):10104. doi: 10.1038/s41598-019-46642-6.

26.

Intractable axonal neuropathy with multifocal peripheral nerve swelling in neuromyelitis optica spectrum disorders: A case report.

Mizuno Y, Shinoda K, Watanabe M, Ogata H, Isobe N, Matsushita T, Yamasaki R, Tanaka K, Koike H, Katsuno M, Kira JI.

Mult Scler Relat Disord. 2019 Oct;35:16-18. doi: 10.1016/j.msard.2019.06.033. Epub 2019 Jun 29.

PMID:
31279231
27.

Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy.

Ikeda S, Koike H, Nishi R, Kawagashira Y, Iijima M, Katsuno M, Sobue G.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):988-996. doi: 10.1136/jnnp-2019-320741. Epub 2019 Jun 21.

PMID:
31227562
28.

Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.

Riku Y, Duyckaerts C, Boluda S, Plu I, Le Ber I, Millecamps S, Salachas F; Brainbank NeuroCEB Neuropathology Network, Yoshida M, Ando T, Katsuno M, Sobue G, Seilhean D.

Acta Neuropathol. 2019 Nov;138(5):783-793. doi: 10.1007/s00401-019-02028-6. Epub 2019 May 29.

PMID:
31144027
29.

Alterations in Cognition-Related Cerebello-Cerebral Networks in Multiple System Atrophy.

Kawabata K, Hara K, Watanabe H, Bagarinao E, Ogura A, Masuda M, Yokoi T, Kato T, Ohdake R, Ito M, Katsuno M, Sobue G.

Cerebellum. 2019 Aug;18(4):770-780. doi: 10.1007/s12311-019-01031-7.

PMID:
31069705
30.

Clinical correlates of repetitive speech disorders in Parkinson's disease.

Tsuboi T, Watanabe H, Tanaka Y, Ohdake R, Sato M, Hattori M, Kawabata K, Hara K, Nakatsubo D, Maesawa S, Kajita Y, Katsuno M, Sobue G.

J Neurol Sci. 2019 Jun 15;401:67-71. doi: 10.1016/j.jns.2019.04.012. Epub 2019 Apr 11.

PMID:
31029883
31.

Long-term Effects of Androgen Deprivation in a Patient with Spinal and Bulbar Muscular Atrophy - A Case Report with 14 Years of Follow-up.

Hijikata Y, Hashizume A, Yamada S, Ito D, Banno H, Suzuki K, Sobue G, Katsuno M.

Intern Med. 2019 Aug 1;58(15):2231-2234. doi: 10.2169/internalmedicine.1592-18. Epub 2019 Apr 17.

32.

DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5.

Kondo N, Tohnai G, Sahashi K, Iida M, Kataoka M, Nakatsuji H, Tsutsumi Y, Hashizume A, Adachi H, Koike H, Shinjo K, Kondo Y, Sobue G, Katsuno M.

EMBO Mol Med. 2019 May;11(5). pii: e8547. doi: 10.15252/emmm.201708547.

33.

DEFENSIVE Stroke Scale: Novel Diagnostic Tool for Predicting Posterior Circulation Infarction in the Emergency Department.

Yamada S, Yasui K, Kawakami Y, Hasegawa Y, Katsuno M.

J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1561-1570. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.005. Epub 2019 Mar 28.

PMID:
30930243
34.

Hereditary Angioedema Type 1 with Recurrent Dizziness.

Ando T, Torii R, Kazuta T, Endo T, Araki A, Horiuchi T, Terao S, Katsuno M.

Intern Med. 2019 Jul 1;58(13):1961-1963. doi: 10.2169/internalmedicine.2015-18. Epub 2019 Mar 28.

35.

Disease Affects Bdnf Expression in Synaptic and Extrasynaptic Regions of Skeletal Muscle of Three SBMA Mouse Models.

Halievski K, Nath SR, Katsuno M, Adachi H, Sobue G, Breedlove SM, Lieberman AP, Jordan CL.

Int J Mol Sci. 2019 Mar 15;20(6). pii: E1314. doi: 10.3390/ijms20061314.

36.

Increase of arginine dimethylation correlates with the progression and prognosis of ALS.

Ikenaka K, Atsuta N, Maeda Y, Hotta Y, Nakamura R, Kawai K, Yokoi D, Hirakawa A, Taniguchi A, Morita M, Mizoguchi K, Mochizuki H, Kimura K, Katsuno M, Sobue G.

Neurology. 2019 Apr 16;92(16):e1868-e1877. doi: 10.1212/WNL.0000000000007311. Epub 2019 Mar 13.

PMID:
30867270
37.

Inflammatory myopathy associated with PD-1 inhibitors.

Seki M, Uruha A, Ohnuki Y, Kamada S, Noda T, Onda A, Ohira M, Isami A, Hiramatsu S, Hibino M, Nakane S, Noda S, Yutani S, Hanazono A, Yaguchi H, Takao M, Shiina T, Katsuno M, Nakahara J, Matsubara S, Nishino I, Suzuki S.

J Autoimmun. 2019 Jun;100:105-113. doi: 10.1016/j.jaut.2019.03.005. Epub 2019 Mar 10.

PMID:
30862448
38.

Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials.

Hashizume A, Katsuno M, Suzuki K, Banno H, Takeuchi Y, Kawashima M, Suga N, Mano T, Araki A, Hijikata Y, Hirakawa A, Sobue G; JASMITT study group.

J Neurol. 2019 May;266(5):1211-1221. doi: 10.1007/s00415-019-09251-x. Epub 2019 Mar 7.

PMID:
30847645
39.

Vasculitic neuropathy with anti-phosphatidylserine/prothrombin complex antibody.

Ando T, Iijima M, Fukami Y, Nishi R, Ikeda S, Yokoi S, Kawagashira Y, Koike H, Muro Y, Katsuno M.

Muscle Nerve. 2019 Jun;59(6):E44-E46. doi: 10.1002/mus.26458. Epub 2019 Mar 14. No abstract available.

PMID:
30810234
40.

Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights.

Koike H, Katsuno M.

Biomedicines. 2019 Feb 5;7(1). pii: E11. doi: 10.3390/biomedicines7010011. Review.

41.

Ultrastructural mechanisms of macrophage-induced demyelination in CIDP.

Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G.

Neurology. 2018 Dec 4;91(23):1051-1060. doi: 10.1212/WNL.0000000000006625. Epub 2018 Nov 14. Review.

PMID:
30429275
42.

[Nonstenotic Carotid Plaque in Patients with Anterior Circulation Embolic Stroke of Undetermined Source].

Hirunagi T, Miwa S, Katsuno M.

Brain Nerve. 2018 Nov;70(11):1295-1299. doi: 10.11477/mf.1416201176. Japanese.

PMID:
30416123
43.

New teased-fibre definitions represent specific mechanisms of neuropathy.

Koike H, Katsuno M, Sobue G.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):124. doi: 10.1136/jnnp-2018-319493. Epub 2018 Nov 1. No abstract available.

PMID:
30385485
44.

Age-related impairment in Addenbrooke's cognitive examination revised scores in patients with amyotrophic lateral sclerosis.

Masuda M, Watanabe H, Tanaka Y, Ohdake R, Ogura A, Yokoi T, Imai K, Kawabata K, Riku Y, Hara K, Nakamura R, Atsuta N, Katsuno M, Sobue G.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):578-584. doi: 10.1080/21678421.2018.1510009. Epub 2018 Oct 31.

PMID:
30379106
45.

Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer's Disease: A PET (THK5351, PiB) and Resting fMRI Study.

Yokoi T, Watanabe H, Yamaguchi H, Bagarinao E, Masuda M, Imai K, Ogura A, Ohdake R, Kawabata K, Hara K, Riku Y, Ishigaki S, Katsuno M, Miyao S, Kato K, Naganawa S, Harada R, Okamura N, Yanai K, Yoshida M, Sobue G.

Front Aging Neurosci. 2018 Oct 5;10:304. doi: 10.3389/fnagi.2018.00304. eCollection 2018.

46.

IGF-1 for spinal and bulbar muscular atrophy: hope and challenges.

Hashizume A, Katsuno M.

Lancet Neurol. 2018 Dec;17(12):1026-1027. doi: 10.1016/S1474-4422(18)30359-4. Epub 2018 Oct 15. No abstract available.

PMID:
30337274
47.

The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study.

Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Sakurai T, Shimohata T, Katsuno M, Sobue G.

J Neurol Sci. 2018 Nov 15;394:99-106. doi: 10.1016/j.jns.2018.09.011. Epub 2018 Sep 12.

PMID:
30243104
48.

Preclinical progression of neurodegenerative diseases.

Katsuno M, Sahashi K, Iguchi Y, Hashizume A.

Nagoya J Med Sci. 2018 Aug;80(3):289-298. doi: 10.18999/nagjms.80.3.289. Review.

49.

Acute Unilateral Isolated Oculomotor Nerve Palsy in an Adult Patient with Influenza A.

Senda J, Araki K, Tachi Y, Watanabe H, Kagawashira Y, Ito M, Atsuta N, Katsuno M, Watanabe H, Sobue G.

Intern Med. 2019 Feb 1;58(3):433-436. doi: 10.2169/internalmedicine.0850-18. Epub 2018 Sep 12.

50.

Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS).

Yamada S, Hashizume A, Hijikata Y, Inagaki T, Ito D, Kinoshita F, Nakatochi M, Kobayashi Y, Hirakawa A, Nakamura T, Katsuno M.

BMJ Open. 2018 Sep 11;8(9):e023041. doi: 10.1136/bmjopen-2018-023041.

Supplemental Content

Loading ...
Support Center